Natco Pharma Limited · NSE: NATCOPHARM · BSE: 524816
Natco Pharma
Quarterly results as filed with BSE. Latest: Q1 FY27 (Apr–Jun 2026), filed 14 Aug 2026.
Q1 FY27 · Consolidated
Revenue
735.20₹ Cr
−44.7% vs year ago
Net profit
206.50₹ Cr
−57.0% vs year ago
EPS, basic
11.53₹
−57.0% vs year ago
Net margin
28.1%
−8.1 pts vs year ago
Quarter by quarter
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 735.20 | −44.7% | 206.50 | −57.0% | 11.53 | 14 Aug 2026 |
| Q4 FY26Jan–Mar 2026 | 739.10 | −39.5% | 269.00 | −33.7% | 14.96 | 29 May 2026 |
| Q3 FY26Oct–Dec 2025 | 647.30 | +36.3% | 151.30 | +14.3% | 8.46 | 12 Feb 2026 |
| Q2 FY26Jul–Sep 2025 | 1,363.00 | −0.6% | 517.90 | −23.4% | 28.94 | 14 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 1,328.90 | −2.5% | 480.30 | −28.2% | 26.84 | 12 Aug 2025 |
| Q4 FY25Jan–Mar 2025 | 1,221.00 | +14.3% | 406.00 | +5.1% | 22.70 | 28 May 2025 |
| Q3 FY25Oct–Dec 2024 | 474.80 | −37.4% | 132.40 | −37.8% | 7.43 | 12 Feb 2025 |
| Q2 FY25Jul–Sep 2024 | 1,371.10 | +32.9% | 676.50 | +83.3% | 37.81 | 12 Nov 2024 |
| Q1 FY25Apr–Jun 2024 | 1,362.60 | +19.5% | 668.50 | +59.1% | 37.32 | 13 Aug 2024 |
| Q4 FY24Jan–Mar 2024 | 1,068.30 | +19.0% | 386.30 | +40.1% | 21.56 | 27 May 2024 |
| Q3 FY24Oct–Dec 2023 | 758.60 | +54.0% | 212.70 | +241.4% | 11.88 | 15 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 1,031.40 | +138.7% | 369.00 | +549.6% | 20.60 | 15 Nov 2023 |
| Q1 FY24Apr–Jun 2023 | 1,140.50 | +28.9% | 420.30 | +31.2% | 23.26 | 09 Aug 2023 |
| Q4 FY23Jan–Mar 2023 | 897.90 | +50.5% | 275.80 | Turned profit | 15.11 | 29 May 2023 |
| Q3 FY23Oct–Dec 2022 | 492.50 | −12.1% | 62.30 | −22.5% | 3.41 | 09 Feb 2023 |
| Q2 FY23Jul–Sep 2022 | 432.10 | +14.6% | 56.80 | −12.7% | 3.11 | 10 Nov 2022 |
| Q1 FY23Apr–Jun 2022 | 884.60 | +115.6% | 320.40 | +327.2% | 17.55 | 10 Aug 2022 |
| Q4 FY22Jan–Mar 2022 | 596.80 | +80.1% | (50.50) | Turned loss | (2.77) | 31 May 2022 |
| Q3 FY22Oct–Dec 2021 | 560.50 | +57.8% | 80.40 | +26.8% | 4.41 | 14 Feb 2022 |
| Q2 FY22Jul–Sep 2021 | 377.20 | −53.0% | 65.10 | −68.1% | 3.57 | 11 Nov 2021 |
| Q1 FY22Apr–Jun 2021 | 410.30 | −27.2% | 75.00 | −38.6% | 4.11 | 12 Aug 2021 |
| Q4 FY21Jan–Mar 2021 | 331.30 | −27.2% | 53.00 | −43.1% | 2.91 | 17 Jun 2021 |
| Q3 FY21Oct–Dec 2020 | 355.20 | −26.3% | 63.40 | −39.3% | 3.44 | 11 Feb 2021 |
| Q2 FY21Jul–Sep 2020 | 802.20 | +65.2% | 203.90 | +73.2% | 11.12 | 12 Nov 2020 |
| Q1 FY21Apr–Jun 2020 | 563.40 | +14.4% | 122.10 | −14.5% | 6.74 | 12 Aug 2020 |
| Q4 FY20Jan–Mar 2020 | 454.80 | −0.2% | 93.20 | −22.6% | 5.17 | 17 Jun 2020 |
| Q3 FY20Oct–Dec 2019 | 482.20 | −13.4% | 104.40 | −34.5% | 5.75 | 12 Feb 2020 |
| Q2 FY20Jul–Sep 2019 | 485.70 | −10.6% | 117.70 | −35.2% | 6.55 | 12 Nov 2019 |
| Q1 FY20Apr–Jun 2019 | 492.30 | −8.6% | 142.80 | −21.1% | 7.87 | 10 Aug 2019 |
| Q4 FY19Jan–Mar 2019 | 455.70 | — | 120.40 | — | 6.59 | 27 May 2019 |
| Q3 FY19Oct–Dec 2018 | 556.70 | — | 159.30 | — | 8.65 | 12 Feb 2019 |
| Q2 FY19Jul–Sep 2018 | 543.50 | — | 181.60 | — | 9.89 | 07 Nov 2018 |
| Q1 FY19Apr–Jun 2018 | 538.60 | — | 181.10 | — | 9.84 | 08 Aug 2018 |
Standalone results
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 596.60 | −50.0% | 74.60 | −83.9% | 4.17 | 14 Aug 2026 |
| Q4 FY26Jan–Mar 2026 | 608.80 | −47.4% | 209.60 | −51.0% | 11.70 | 29 May 2026 |
| Q3 FY26Oct–Dec 2025 | 528.80 | +29.7% | 106.90 | −14.4% | 5.97 | 12 Feb 2026 |
| Q2 FY26Jul–Sep 2025 | 1,264.30 | −2.2% | 500.90 | −24.2% | 27.97 | 14 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 1,192.70 | −3.6% | 464.10 | −27.1% | 25.91 | 12 Aug 2025 |
| Q4 FY25Jan–Mar 2025 | 1,157.40 | +20.0% | 428.10 | +22.6% | 23.90 | 28 May 2025 |
| Q3 FY25Oct–Dec 2024 | 407.60 | −34.8% | 124.90 | −34.9% | 6.97 | 12 Feb 2025 |
| Q2 FY25Jul–Sep 2024 | 1,292.60 | +38.9% | 661.10 | +83.5% | 36.91 | 12 Nov 2024 |
| Q1 FY25Apr–Jun 2024 | 1,236.90 | +18.0% | 636.30 | +57.0% | 35.53 | 13 Aug 2024 |
| Q4 FY24Jan–Mar 2024 | 964.80 | +23.5% | 349.10 | +37.4% | 19.49 | 27 May 2024 |
| Q3 FY24Oct–Dec 2023 | 625.30 | +51.4% | 192.00 | +414.7% | 10.72 | 15 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 930.50 | +165.0% | 360.20 | +855.4% | 20.11 | 15 Nov 2023 |
| Q1 FY24Apr–Jun 2023 | 1,048.30 | +30.1% | 405.30 | +31.6% | 22.43 | 09 Aug 2023 |
| Q4 FY23Jan–Mar 2023 | 781.20 | +52.0% | 254.10 | Turned profit | 13.92 | 29 May 2023 |
| Q3 FY23Oct–Dec 2022 | 413.00 | −22.0% | 37.30 | −47.9% | 2.04 | 09 Feb 2023 |
| Q2 FY23Jul–Sep 2022 | 351.10 | +6.3% | 37.70 | −29.7% | 2.07 | 10 Nov 2022 |
| Q1 FY23Apr–Jun 2022 | 805.70 | +104.6% | 308.00 | +309.6% | 16.87 | 10 Aug 2022 |
| Q4 FY22Jan–Mar 2022 | 514.10 | +65.0% | (61.30) | Turned loss | (3.36) | 31 May 2022 |
| Q3 FY22Oct–Dec 2021 | 529.50 | +60.0% | 71.60 | +30.9% | 3.93 | 14 Feb 2022 |
| Q2 FY22Jul–Sep 2021 | 330.40 | −31.0% | 53.60 | −24.4% | 2.94 | 11 Nov 2021 |
| Q1 FY22Apr–Jun 2021 | 393.80 | −26.0% | 75.20 | −40.6% | 4.12 | 12 Aug 2021 |
| Q4 FY21Jan–Mar 2021 | 311.50 | −25.9% | 57.20 | −43.4% | 3.14 | 17 Jun 2021 |
| Q3 FY21Oct–Dec 2020 | 330.90 | −26.1% | 54.70 | −47.2% | 3.00 | 11 Feb 2021 |
| Q2 FY21Jul–Sep 2020 | 478.90 | +4.6% | 70.90 | −42.0% | 3.89 | 12 Nov 2020 |
| Q1 FY21Apr–Jun 2020 | 532.20 | +14.5% | 126.70 | −14.2% | 6.96 | 12 Aug 2020 |
| Q4 FY20Jan–Mar 2020 | 420.10 | +0.9% | 101.00 | −18.2% | 5.55 | 17 Jun 2020 |
| Q3 FY20Oct–Dec 2019 | 447.70 | −15.8% | 103.60 | −36.0% | 5.70 | 12 Feb 2020 |
| Q2 FY20Jul–Sep 2019 | 457.70 | −12.4% | 122.20 | −36.7% | 6.72 | 12 Nov 2019 |
| Q1 FY20Apr–Jun 2019 | 464.70 | −9.9% | 147.70 | −21.7% | 8.11 | 10 Aug 2019 |
| Q4 FY19Jan–Mar 2019 | 416.30 | — | 123.40 | — | 6.73 | 27 May 2019 |
| Q3 FY19Oct–Dec 2018 | 531.90 | — | 162.00 | — | 8.78 | 12 Feb 2019 |
| Q2 FY19Jul–Sep 2018 | 522.40 | — | 193.10 | — | 10.47 | 07 Nov 2018 |
| Q1 FY19Apr–Jun 2018 | 515.70 | — | 188.60 | — | 10.22 | 08 Aug 2018 |
66 filings on record for this company.